Stay updated on Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Sign up to get notified when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page

  1. Check
    7 days ago
    Change Detected
    Summary
    Updated view shows cosmetic UI and layout adjustments (header styling and spacing). Core study data such as enrollment, eligibility criteria, outcomes, and status appear unchanged.
    Difference
    0.2%
    Check dated 2026-03-13T20:20:13.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    The page now shows 'Results Submitted' replacing 'No Results Posted,' and the revision is updated to v3.4.3.
    Difference
    0.3%
    Check dated 2026-03-06T18:39:56.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    The study record now shows a Terminated Sponsor decision banner, indicating the trial has been terminated. This update changes the status of the study and informs potential participants and investigators about its closure.
    Difference
    0.2%
    Check dated 2026-02-27T18:56:43.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    No additions or deletions detected; the screenshots show the same study details and page layout.
    Difference
    0.2%
    Check dated 2026-02-20T16:50:27.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Revision: v3.4.2 released. No visible changes to the study details or navigation.
    Difference
    0.3%
    Check dated 2026-02-13T15:28:34.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1; no visible content changes to the study details or page functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2026-02-06T09:22:21.000Z thumbnail image

Stay in the know with updates to Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Vatiquinone for Mitochondrial Disease and Refractory Epilepsy Clinical Trial page.